BRIM Biotechnology, Inc. (TPE:6885)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.10
+0.55 (1.93%)
Nov 13, 2026, 1:30 PM CST

BRIM Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
232.13798.43502.76948837.99399.75
Short-Term Investments
688.213601,346747.63-23.84
Cash & Short-Term Investments
920.331,1581,8491,696837.99423.59
Cash Growth
-28.21%-37.34%9.03%102.34%97.83%149.98%
Accounts Receivable
1.130.63----
Other Receivables
6.5441.8223.366.240.450.37
Receivables
7.6742.4623.366.240.450.37
Inventory
1.620.67----
Prepaid Expenses
49.656.994.0711.110.556.65
Other Current Assets
0.320.140---
Total Current Assets
979.591,2091,8761,713848.99430.61
Property, Plant & Equipment
8.0614.5111.796.377.993.62
Long-Term Investments
73.7523.5538.2757.382.3360.35
Goodwill
-67.56----
Other Intangible Assets
522.1512.06483.391.340.09-
Other Long-Term Assets
1.361.371.020.70.590.86
Total Assets
1,5851,8282,4111,779939.99495.44

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.50.85----
Accrued Expenses
-47.3615.5236.0416.9912.34
Current Portion of Long-Term Debt
-2.97----
Current Portion of Leases
0.695.844.233.483.632.85
Current Unearned Revenue
3.170.83----
Other Current Liabilities
38.99.09331.082.521.872.05
Total Current Liabilities
44.2666.94350.8442.0522.4817.23
Long-Term Debt
4.976.46----
Long-Term Leases
-0.683.540.112.810.32
Total Liabilities
49.2374.08354.3842.1625.317.55

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,3311,3321,3151,158932.54692.54
Additional Paid-In Capital
812.261,3641,6361,725589.72454.31
Retained Earnings
-900.15-1,021-884.69-1,149-771.19-746.92
Comprehensive Income & Other
224.65-20.38-9.852.95163.6377.96
Total Common Equity
1,4681,6552,0561,737914.69477.89
Minority Interest
67.8798.64----
Shareholders' Equity
1,5361,7542,0561,737914.69477.89
Total Liabilities & Equity
1,5851,8282,4111,779939.99495.44

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
5.6615.967.783.596.443.16
Net Cash (Debt)
914.671,1421,8411,692831.55420.42
Net Cash Growth
-27.45%-37.94%8.80%103.48%97.79%157.57%
Net Cash Per Share
6.958.6915.7816.8311.667.09
Filing Date Shares Outstanding
131.92133.21131.5115.7593.2569.25
Total Common Shares Outstanding
131.92133.21131.5115.7593.2569.25
Working Capital
935.331,1421,5251,671826.51413.38
Book Value Per Share
11.1312.4215.6415.009.816.90
Tangible Book Value
945.641,0751,5731,735914.6477.89
Tangible Book Value Per Share
7.178.0711.9614.999.816.90
Machinery
-15.999.126.464.843.59
Leasehold Improvements
-3.673.673.443.193.07